The Office of the Assistant Secretary for Health (OASH) Office on Women's Health (OWH) announces the anticipated availability of funds for Fiscal Year (FY) 2026 grants under the authority of section 229 of the Public Health Service (PHS) Act (42 U.S.C. § 237a), section 1703(a) of the PHS Act (42 U.S.C. § 300u-2(a)), and all of the authorities under Title XVII of the Public Health Service Act, as amended, pertaining to the mission of the Office on Women's Health." 73 Fed. Reg. 62995 (Oct 2008).This notice solicits applications from organizations with demonstrated experience in the prevention, diagnosis, and treatment of reproductive health conditions, which may include polyendocrine metabolic ovarian syndrome (PMOS, formerly known as polycystic ovary syndrome or PCOS), endometriosis, uterine fibroids, infertility, pelvic inflammatory disease (PID), reproductive-age endocrine disorders, or recurrent miscarriage. Through this cooperative agreement, selected organizations will be recognized and elevated as a Center of Excellence, building on their existing expertise to strengthen the translation of evidence into practice, enhance and standardize root-cause care pathways, expand workforce training, and improve health outcomes for women. OWH encourages applicants to review all program requirements, eligibility information, application format and submission information, evaluation criteria, and other information in this funding announcement to ensure that their application complies with all requirements and instructions.